SCHEMBL7183516

SCHEMBL7183516

C/C=C/Cc1cc(C/C=C/C)c(OCC)c(/C=C/C(=O)c2ccc(N)cc2)c1O

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
KRAS P01116 1/20 0.42
CTSL P07711 1/20 0.41
CTSB P07858 1/20 0.41
MAOB P27338 5/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
CYP1B1 Q16678 5/20 0.40
CYP1A1 P04798 4/20 0.40
CYP1A2 P05177 3/20 0.40
CYP2D6 P10635 3/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PTPN1 P18031 2/20 0.39
MAOA P21397 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7183517 1.00 CA1 (0.42) CA1CA2KRASCTSLCTSB
SCHEMBL7191423 0.92 ABCG2 (0.49) CTSLCTSBMAOBABCG2CYP1B1
SCHEMBL7191429 0.92 ABCG2 (0.49) CTSLCTSBMAOBABCG2CYP1B1
SCHEMBL7190229 0.92 ABCG2 (0.42) CA1CA2KRASCTSLCTSB
SCHEMBL7190226 0.92 ABCG2 (0.42) CA1CA2KRASCTSLCTSB
SCHEMBL9204802 0.90 CA1 (0.43) CA1CA2KRASCTSLCTSB
SCHEMBL9204807 0.90 CA1 (0.43) CA1CA2KRASCTSLCTSB
SCHEMBL7180122 0.89 PTPN1 (0.49) CA1CA2KRASCTSLCTSB
SCHEMBL7180126 0.89 PTPN1 (0.49) CA1CA2KRASCTSLCTSB
SCHEMBL7188097 0.89 CA1 (0.52) CA1CA2KRASCTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed